 |
 |
References
Chen S, Sorrell T, Nimmo G, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Clin Infect Dis 2000;31:499-508.Hajjeh RA, Brandt ME, Pinner RW. Emergence of cryptococcal disease: epidemiologic perspectives 100 years after its discovery. Epidemiol Rev 1996;17:303-320.
Hajjeh RA, Conn LA, Stephens DS, et al. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. J Infect Dis 1999;179:449-454.
Mirza SA, Phelan M, Rimland D, et al. The changing epidemiology of cryptococcosis: an update from population-based active surveillance in 2 large metropolitan areas, 1992-2000. Clin Infect Dis 2003; 36: 789-794.
Pappas PG, Perfect JR, Cloud GA, et al. Cryptococcosis in human immunodeficiency virus- negative patients in the era of effective azole therapy. Clin Infect Dis 2001; 33: 690-699.
Perfect JR, Casadevall A. Cryptococcosis. Infect Dis Clin North Am 2002; 16: 837-874.
Saag MS, Graybill JR, Larsen RA, et al. Practice guidelines for the management of cryptococcal disease. Clin Infect Dis 2000;30:710-718.